The CDC said on Friday said it should resume use of Johnson & Johnson's COVID-19 vaccine, despite a very rare risk of blood clots.
The CDC said on Friday said it should resume use of Johnson & Johnson's COVID-19 vaccine, despite a very rare risk of blood clots.
The CDC said anxiety-related side effects can happen from any of the vaccines. It said fainting was more common after the Johnson &..